About: Promising activity of mammalian target of rapamycin inhibitors in hematologic malignancies therapy     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • The mammalian target of rapamycin (mTOR) is a downstream mediator of the phosphatidylinositol 3-kinase (PI3K)/Akt (protein kinase B) signaling pathway which regulates cell survival and proliferation. mTOR is a highly conserved serine/treonine kinase involved in the control of cell growth, protein synthesis, and cell cycle progression. Inhibitor of mTOR pathway have antiproliferative properties in hematological malignancies and are studied in therapeutic trials
  • The mammalian target of rapamycin (mTOR) is a downstream mediator of the phosphatidylinositol 3-kinase (PI3K)/Akt (protein kinase B) signaling pathway which regulates cell survival and proliferation. mTOR is a highly conserved serine/treonine kinase involved in the control of cell growth, protein synthesis, and cell cycle progression. Inhibitor of mTOR pathway have antiproliferative properties in hematological malignancies and are studied in therapeutic trials (en)
Title
  • Promising activity of mammalian target of rapamycin inhibitors in hematologic malignancies therapy
  • Promising activity of mammalian target of rapamycin inhibitors in hematologic malignancies therapy (en)
skos:prefLabel
  • Promising activity of mammalian target of rapamycin inhibitors in hematologic malignancies therapy
  • Promising activity of mammalian target of rapamycin inhibitors in hematologic malignancies therapy (en)
skos:notation
  • RIV/00023736:_____/11:00009171!RIV12-MZ0-00023736
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(LC06044), Z(MZ0UHKT2005)
http://linked.open...iv/cisloPeriodika
  • 1
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 224625
http://linked.open...ai/riv/idVysledku
  • RIV/00023736:_____/11:00009171
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • hematological malignancies; Mammalian target of rapamycin; Phosphatase and tensin homologue tumor suppressor; Phosphatidylinositol 3-kinase; Protein kinase B; TOR inhibitors (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • AE - Stát Spojené arabské emiráty
http://linked.open...ontrolniKodProRIV
  • [9C1791562316]
http://linked.open...i/riv/nazevZdroje
  • Current Signal Transduction Therapy
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 6
http://linked.open...iv/tvurceVysledku
  • Fuchs, Ota
http://linked.open...n/vavai/riv/zamer
issn
  • 1574-3624
number of pages
http://bibframe.org/vocab/doi
  • 10.2174/157436211794109460
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 77 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software